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Abstract 
Aims: To critically appraise and synthesise the best available evidence on the effectiveness of 
interventions suitable for delivery by nurses, designed to enhance cardiac patients’ adherence 
to their prescribed medications.  
Background: Cardiac medications have significant health benefits for patients with heart 
disease, but patients’ adherence to prescribed medications remains suboptimal. 
Design: A systematic quantitative review of intervention effects. 
Data Sources: We conducted systematic searches for English-language, peer-reviewed 
randomised controlled trial publications via Medline, EMBASE, CINAHL, the Cochrane 
Library, ProQuest, Web of Science and Google Scholar published between January 2004 and 
December 2014.  
Review methods. According to pre-determined inclusion and exclusion criteria, eligible 
studies were identified and data extracted using a predefined form. Of 1,962 identified 
papers; 14 studies met the study inclusion criteria, were assessed for risk of bias using the 
Cochrane Collaboration tool; and included in the review. 
Results: Study findings were presented descriptively; due to the heterogeneity of studies 
meta-analysis was not possible. Included papers described interventions categorised as: 1) 
multifaceted, and 2) behavioural and educational, comprising: 2a) text message and mail 
message, 2b) telephone calls, 2c) motivational interviewing and 2d) nurse-led counselling 
and education. 
Conclusions: Substantial heterogeneity limited the robustness of conclusions, but this review 
indicated that motivational interviewing, education, and phone or text messaging appeared 
promising as means to enhance cardiac medication adherence. Future research should 
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integrate multifaceted interventions that target individual behaviour change to enhance 
adherence to cardiovascular medications, to build on the beneficial outcomes indicated by 





Why is this research or review needed? 
 Non-adherence to cardiovascular medicines is associated with greater risk of 
hospitalisation and mortality.  
 Various studies examine the effectiveness of medication adherence interventions, but 
the evidence is inconsistent and unclear. 
 Nurses play a key role in educating and supporting patients with their medication, but 
evidence is lacking for effective nurse-delivered interventions to promote medication 
adherence for cardiac patients.  
What are the key findings? 
 Multifaceted interventions that target individual behaviour change appear to offer 
most promising methods to enhance adherence to cardiovascular medications.   
 Current evidence indicates that the components for multifaceted interventions most 
likely to sustain adherence to cardiac medication-taking include motivational 
interviewing, education and phone or text messaging. 
How should the findings be used to influence policy/ practice/research? 
 Findings provide evidence to support clinicians’ choice of interventions designed to 




 Rigorous methods are required for future studies to test the effectiveness of nurse-led 
adherence interventions, taking into account study design, sampling, choice of 
effective and feasible adherence measures, ways to accommodate interventions within 
routine daily practice and longer term sustainability of outcomes.  
 Policy-makers should consider the opportunities offered by nurse-led medication 
adherence interventions, to enhance the contribution of nurses and thereby optimise 
the benefits to patients of their prescribed medications.  
Keywords: cardiovascular medication, adherence, cardiac disease, systematic review, text 
message, motivational interviewing, education, nursing, nurse-led intervention.   
Introduction  
Medication non-adherence is a complex problem that poses an enormous health and 
economic burden. It is more common among older age population and patients who need 
multiple medications for their chronic conditions (Menditto et al. 2015). It has been estimated 
that inadequate adherence to treatment among patients with chronic diseases affects up to 
50% of patients (Lee et al. 2006, Wilke et al. 2011). Non-adherence is a multifactorial 
phenomenon, affected by socio-economic status, health systems, disease states, 
pharmacological therapies and patient beliefs (Sabaté 2003). Supporting long-term adherence 
to medicines is an essential component of patient management and requires effective 
interventions to help achieve sustained medication-taking. This systematic review therefore 
aimed to identify effective interventions used by nurses to improve cardiac patients’ 
adherence to cardiac medications. 
Background 
Cardiovascular disease (CVD) remains the leading cause of mortality among men and women 
and is responsible for one third of all deaths worldwide (World Health Organisation 2004). In 
developing countries, coronary heart disease (CHD) accounts for more than 4.5 million 
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deaths per annum (Okrainec et al. 2004). Similar to international trends, CVD is the single 
greatest cause of death in Australia, accounting for the deaths of 11,733 males and 9,780 
females in 2011(Australian Institute of Health and Welfare 2014). Although CHD is 
incurable, disease progress can be significantly slowed by cardio-protective medicines and 
lifestyle changes. Cardio-protective medicines are the primary therapy for CHD, but 
adherence to these medications is suboptimal, resulting in insufficient control of disease 
symptoms and increased risk of future cardiovascular events, rehospitalisation and death 
(Baroletti& Dell'Orfano 2010). The World Health Organisation define adherence as “the 
extent to which a person’s behaviour (taking medications, following a recommended diet 
and/or executing life-style changes) corresponds with the agreed recommendations of a 
health care provider” (Sabaté 2003). Adherence to medication recommendations is necessary 
to receive the full beneﬁts of the medications. Medication non-adherence has been defined as 
“taking less than 80% of prescribed doses and can also include taking too many doses”, and it 
is associated with an increased risk of poor health, adverse clinical events, and death 
(Nieuwlaat et al. 2014). It is estimated that up to 50% of patients with CHD in high income 
countries do not take their medications as prescribed (Laba et al. 2013). Poor medication 
adherence has been linked to recurrent cardiac events and adverse patient outcomes (Poluzzi 
et al. 2011, Nieuwlaat et al. 2014).  
The prevalence of patients in the aging Australian population who are non-adherent to 
cardiovascular medications has been reported to range from 14% to 43%, posing a serious 
barrier to secondary prevention (McKenzie et al. 2015). Thus, long term medication 
adherence in Australia remains unsatisfactory, with the situation changing only very slowly 
(Simons et al. 2011). Poor medication adherence rates undermine the translation of the 
benefits of well-established evidence-based cardiovascular medicines into practice, reducing 
the effectiveness of secondary prevention therapies (Haynes et al. 2005). It is crucial that 
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adherence to cardiovascular medicines is optimised to improve disease symptoms and 
prevent the onset of further serious cardiac events (van Dalem et al. 2012).  
The effectiveness of a wide variety of interventions intended to enhance medication 
adherence in patients with CHD has been trialled. A number of diverse and complex 
behavioural, educational, and combined intervention approaches and outcomes measures 
have emerged; however, the effectiveness of these interventions needs to be carefully 
evaluated due to the diverse methodologies used in the studies. It is important that healthcare 
professionals are aware of effective practical strategies and have the necessary skills to 
translate these interventions to outpatient healthcare settings. The purpose of this systematic 
review was to identify and synthesise the best available evidence on the effectiveness of 
interventions within the nursing scope of practice, designed to enhance cardiac patients’ 
adherence to cardio-protective medications. 
The review 
Aims 
Many and varied approaches have been trialled with the intention of enhancing medication 
adherence, but what interventions suitable for delivery by nurses are effective at improving 
the adherence of cardiac patients to their prescribed cardio-protective medications?  
Design 
A systematic quantitative review of intervention effects was conducted according to the 
principles and processes of the Cochrane Handbook for Systematic Reviews of Interventions 
(Higgins& Green 2008). GRADE was used for grading the quality of evidence provided by 
findings (EPOC Resources for review authors 2013). The PRISMA statement (Moher et al. 




A systematic literature search was conducted using six electronic databases: Medline, 
EMBASE, CINAHL, the Cochrane Library, ProQuest, and Web of Science. These databases 
and Google Scholar were searched for articles published in English between January 2004 
and December 2014. The reference lists of all selected articles including review articles were 
searched for additional studies. The keywords used in the search strategy were based on the 
‘PICOS’ framework (Table 1). 
Studies were included if they were primary research reported the results of un-confounded 
evaluation of interventions suitable for delivery by nurses to increase medication adherence 
for patients with CHD.  The following inclusion criteria were applied: 
1) Study design was a RCT, clinical trial, or controlled clinical trial that examined the 
effectiveness of an intervention to increase adherence to medications among patient with 
cardiac disease, used for secondary prevention or treatment of cardiac disease in which an 
intervention group was compared to a control group who received standard care or a clearly 
justified comparison group; 
2) The population of interest comprised male and female adults (≥18 years old) with a 
diagnosis of a cardiac disease; 
3) The intervention strategy was suitable (within the scope of practice) for delivery by nurses 
and had either a primary or secondary aim to increase the adherence to medication of patient 
with cardiac disease; 
4) Patients were followed for at least 6 months; 
5) Medication was self-administered, that is, was not administered by a health care 
professional or carer, and measured by any method e.g.: pill count, electronic monitoring, 
refill or prescription records, or self-reported data. 
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Studies were excluded if they targeted patients with heart valve disease or post-cardiac 
surgeries; were written in a language other than English; included non-cardiac disease 
patients; tested interventions that required delivery by a non-nursing healthcare professional, 
e.g. pharmacist; were conducted in inpatient settings; and had less than six months follow-up, 
because cardiovascular medications typically require long-term adherence. 
 
Search outcome 
In total, search strategies identified 1,962 citations of potential relevance. Initial screening of 
study titles and abstracts revealed that more than 95% of the retrieved studies did not meet 
the review inclusion criteria, leaving 94 papers for further evaluation. The full texts of these 
papers were then reviewed and 14 studies were retained for assessment. The flow of studies 
through the selection process is summarised in Figure 1. 
Quality appraisal 
The quality of included studies was appraised by three authors (AA, LP & LG). Risk of bias 
assessment is presented in the supplementary online Table S1 using the Cochrane 
Collaboration tool for assessing the risk of bias (Higgins et al. 2011). Risk of bias was 
assessed independently by the authors, and discrepancies were resolved by discussion (Figure 
2).  
Data abstraction 
Data were extracted and analysed by three authors (AA, LP & LG) using a predefined form. 
After quality appraisal of these studies, 14 were retained for the review. Details of data 




Multiple sources of heterogeneity (interventions, adherence measures, and outcomes) were 
observed across the included studies; formal meta-analysis was therefore not appropriate. The 
heterogeneity was explored qualitatively by comparing the characteristics of included studies. 
Studies were grouped according to the main components of the interventions (see the 
supplementary online Table S2).  
Results 
These fourteen included studies contained data on 4,548 patients with cardiac disease. These 
studies were summarised based on the country of origin, participants’ cardiac disease 
diagnostic group, and the practice setting of interventions (Table 2). None of these studies 
detailed or considered the potential effect of socio-demographic, literacy or economic 
characteristics on intervention outcomes. The median follow-up time was one year, ranging 
from six months to 24 months. Most studies achieved their endpoint outcomes at three to nine 
months. Interventions varied, with single, combined, and multifaceted component parts. 
Interventions and study characteristics are detailed in Table S2.  
Risk of bias assessment  
Risk of bias was assessed using the Cochrane Collaboration tool (Higgins et al. 2011) for 
selection, performance, attrition, detection, reporting and systematic bias. All trials provided 
information about adequate sequence generation, ten studies described the measures used to 
blind outcome assessors from group allocation. Four studies avoided performance bias (Jiang 
et al. 2007, Ogedegbe et al. 2008, Beune et al. 2014, Leiva et al. 2014)  by providing 
information about adequate blinding of participants and personal. Ten studies reported 
participants lost to follow up; six trials provided study protocols and reported the methods of 
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outcomes assessment (medication adherence). The remaining studies reported all outcomes 
but without study protocols (Schroeder et al. 2005, Jiang et al. 2007, Ogedegbe et al. 2008, 
Smith et al. 2008, Guirado et al. 2011, Kripalani et al. 2012, Rinfret et al. 2013, Leiva et al. 
2014) (see Figure 2).  
GRADE was used to rate the quality of evidence for medication adherence. Scores ranged -1 
or +1 and were summed to produce overall scores (4 = high, 3 = moderate, 2 = low and 1 = 
very low) based on the risk of bias, design, inconsistency, indirectness and imprecision in 
their scores (EPOC Resources for review authors 2013). Most studies were at low or unclear 
risk of bias and the quality of evidence was rated moderate for the outcomes (Figure 2). 
Hence, study results should be interpreted with caution. 
Medication adherence measurement 
Methods for measuring and monitoring medication regimen adherence varied in these trials. 
Six studies each measured adherence by self-report (Jiang et al. 2007, Guirado et al. 2011, 
Hacihasanoğlu& Goözuöm 2011, Nieuwkerk et al. 2012, Beune et al. 2014, Ma et al. 2014) 
and by pharmacy refill electronic data (Smith et al. 2008, Rinfret et al. 2013, Ho et al. 2014, 
Leiva et al. 2014, Wald et al. 2014). The Medication Event Monitoring System (MEMS) pill 
bottle caps was used in one study (Schroeder et al. 2005), and two studies applied both self-
report and MEMS (Ogedegbe et al. 2008, Kripalani et al. 2012).  
Types of intervention 
Interventions were categorised according to their prominent components and included: 1) 
multifaceted and 2) behavioural and educational interventions. The latter comprised: 2a) text 
message and mail message, 2b) telephone calls, 2c) motivational interviewing, and 2d) nurse-
led counselling and education. The complex nature of some interventions made them difficult 
to categorise, but this was based on the main component of intervention. Three studies 
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examined text message (TM) and/or mail message interventions (Smith et al. 2008, Kripalani 
et al. 2012, Wald et al. 2014); two studies tested multifaceted intervention strategies (Ho et 
al. 2014, Leiva et al. 2014); two studies investigated the effect of structured telephone calls 
(Hacihasanoğlu& Goözuöm 2011, Rinfret et al. 2013); and two studies utilised the 
motivational interviewing approach (Ogedegbe et al. 2008, Ma et al. 2014). Five 
interventions were classified as nurse-led counselling and education (Schroeder et al. 2005, 
Jiang et al. 2007, Guirado et al. 2011, Nieuwkerk et al. 2012, Beune et al. 2014). The 
heterogeneity of interventions, measurement tools and methods precluded meta-analysis of 
baseline and post-intervention rates of adherence for the reviewed studies.  
Multifaceted interventions 
The effectiveness of multifaceted interventions for enhancing medication adherence was 
described and evaluated by two studies. Ho et al. (2014) utilised a four stage multifaceted 
intervention that entailed: medication reconciliation and tailoring, education about 
medications, collaborative care, and two types of scheduled voice messaging (educational 
and medication refill reminder calls). Similarly, Leiva et al. (2014) evaluated a multifaceted 
intervention incorporating motivational interviewing, pillbox reminders, family support, 
blood pressure measurements and antihypertensive reminder forms, and simplification of 
dosing regimens in patients with hypertension. Ho et al. (2014) found that adherence rate 
improved at 12 months follow-up by 89.3% in the intervention arm compared with 73.9% 
with usual care for four classes of medications. On the other hand, Leiva et al. (2014) found 
no significant between groups differences in antihypertensive adherence at 12 months (51.4% 
vs. 50.8%) in intervention and control groups, respectively (Table S2). The Ho et al. (2014) 
study was high quality; however, Leiva et al. (2014) did not employ a blinding process and 
delivery of the intervention by nurses varied according to their characteristics and the 
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methods of delivery, possibly resulting in overestimation of the intervention effect (Tables 
S2). Overall, this type of intervention approach appeared likely to increase adherence to 
medications after hospital discharge post ACS and was costed at $360 per patient per year 
(Ho et al. 2014). 
Text and mail message interventions 
Three studies assessed the effectiveness of text message (TM) (Wald et al. 2014) and mail 
message reminders (Smith et al. 2008, Kripalani et al. 2012). In the Wald et al. (2014) study, 
participants in the intervention group received automatically generated daily TM reminders 
which questioned patients whether they had taken their blood pressure and/or lipid lowering 
medications; whether the message had reminded them to take it; if they had forgotten or 
whether they had simply not taken it. This study showed 16% improvement in medication 
adherence (95% CI 7%–24%, p< 0.001) at 6 months follow-up, and a statistically significant 
difference between groups of patients who had stopped medication completely and those who 
continued to take <80% of the prescribed regimen (Table S2). However, participants’ high 
adherence rates at baseline and unclear randomisation and blinding procedures may have 
resulted in under or overestimation of intervention effects (Tables S1).  
Two studies applied a less individual approach, one mailed graphical postcards focusing on 
refill and other important reminders to patients with CHD (Kripalani et al. 2012), another 
focused on improving cognitive aspects of medication adherence by sending two letters to 
patients and to primary care providers describing the importance of beta-blockade (Smith et 
al. 2008). Kripalani et al. (2012) showed a non-significant difference in improvements in 
adherence between groups (32.9% vs. 32.9% respectively) whereas the Smith et al. (2008) 
study improved adherence rates among patients in the intervention group by 17%, increasing 
the days covered to 80% in this group (relative risk= 1.17; 95% CI= 1.02-1.29; p= 0.04). The 
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quality of Smith et al. (2008) study was good in terms of randomisation methods, 
intervention and strategies used for applying the intervention and follow-up. By contrast, 
graphical mailed refill reminders failed to improve medication adherence, attributed to 
quality issues with randomisation and blinding processes (Table S1). Overall, the TM and 
mail message approaches appeared potentially effective and feasible strategies as 
reinforcement for taking medication and improving medication adherence. 
Telephone call interventions 
Two studies (Hacihasanoğlu& Goözuöm 2011, Rinfret et al. 2013) examined the use of 
structured phone calls with interactive components to improve medication adherence. 
Hacihasanoğlu& Goözuöm (2011) randomly allocated patients with hypertension to three 
groups to receive a 6-month nurse-based medication educational intervention alone, 
educational intervention plus home monitoring for medication adherence, or a control group. 
Both intervention groups received monthly follow-up phone call interviews providing them 
with information about hypertension. Similarly, in the Rinfret et al. (2013) study, patients 
with dual antiplatelet therapy (DAT) (n=150) were randomised to either nurse phone calls 
within one week and then at one month, six months and nine months to assess adherence, 
reinforce optional drug compliance and discuss the factors affecting adherence or to a control 
group (Table S2). Both studies showed a significant increase in medication adherence using 
different measures. At 10 months follow up, there was a significant increase in regular 
medication intake ratios after education in groups A and B (80%, 85%, respectively, p= 
0.001) but not in the control group (42%, p> 0.05) (Hacihasanoğlu& Goözuöm 2011). 
Combined education (group B) was shown to have a more positive effect on adherence self-
efficacy than education alone (group A) and no intervention (control group) (72.27 (SD= 
5.27); 71.10 (SD= 6.42); 56.85 (SD= 6.10) respectively, F= 83.131; p= 0.001) 
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(Hacihasanoğlu& Goözuöm 2011). The Rinfret et al. (2013) study showed that participants in 
both groups had high adherence to antiplatelet drugs at 12 months, with 99.2% (ranging from 
97.5% to 100%) of the intervention group taking aspirin compared to 90.2% (ranging from 
84.2% to 95.4%) of the control group; clopidogrel, 99.3% (ranging from 97.5% to 100%) in 
the intervention group vs. 91.5% (85.1-96.0%) % in the control group, (p< 0.0001). However, 
the study results may have been biased by the lack of blinding of patients and intervention 
providers, although it was impractical in this study (Table S1).  
Motivational interviewing strategies 
Motivational interviewing has been used as an approach to increase adherence to medication 
in cardiac patients. Ogedegbe et al. (2008) conducted a randomised controlled trial in two 
community-based primary care practices in the US, evaluating the efficacy and effects of 
practice-based motivational interview (MINT) counselling on medication adherence and 
blood pressure in 190 African American patients with hypertension. Based on intention-to-
treat analysis using mixed-effects regression, the MINT group achieved a higher MEMS 
adherence rate at 12 months follow-up compared to the control group (57% vs. 43% 
respectively, p < 0.05), with an absolute between-group difference of 14% (95% CI, −0.2 to –
27%). The MINT group received behavioural counselling about medication adherence for 
30–40 minutes at three, six, nine, and 12 months, which led to steady maintenance of 
medication adherence over 12 months, while adherence rates declined overtime in the control 
group. Similarly, Ma et al. (2014) applied MINT counselling, based on social cognitive 
theory, to 120 patients with hypertension from two community health centres in China. This 
intervention entailed strategies to promote adherence to behaviour changes, summarising the 
pros and cons of proposed behaviour changes, setting realistic and specific goals for 
behaviour modification and prompting patients to follow plans for behaviour change (Table 
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S2). Adherence to medication was improved in the MINT counselling group compared to the 
control group at six months follow-up (29.72 (SD= 3.46) vs. 25.30 (SD= 3.11) respectively, 
(t=0.039, p=0.034). Mean scores for medication adherence were increased within-groups 
with mean difference between baseline and six months for intervention group of (23.25 (SD= 
3.02); 29.72 (SD= 3.46) respectively, (t= 0. 039, P= 0.034) and (22.13 (SD= 2.89); 25.30 
(SD= 3.11) (t= 0. 039, P= 0.061) (Table S2). This form of MINT was theory-based, and 
shown to be effective using accepted valid measures for adherence assessment over longer 
duration of follow-up. 
Nurse-led counselling and education 
Five studies intended to improve medication adherence by using behavioural interventions 
and education through nurse-led counselling. Four studies demonstrated no or little evidence 
of effect (Schroeder et al. 2005, Jiang et al. 2007, Guirado et al. 2011, Beune et al. 2014). 
These results may be attributed in part at least to feature of the research methods, such as 
self-selected populations with high adherence levels at baseline (Schroeder et al. 2005) and 
randomisation and blinding processes bias (Jiang et al. 2007, Guirado et al. 2011, Beune et 
al. 2014) (Table S1). Nieuwkerk et al. (2012) revealed that adherence to lipid lowering 
medication increased from 95% to100% in the intervention group and from 90% to 95% in 
the control group. At 18 months follow up, the intervention group had higher adherence to 
statin therapy than the control group (9.39 (SD= 0.15) vs 8.86 (SD= 0.15)) respectively, with 
an absolute difference between groups of 0.53 (0.02-1.05), (r = -0.36, P< 0.01) (Table S2). 
With 201 patients on statin therapy randomised to receive nurse-led multifactorial cardio-
vascular risk-factor counselling or standard care, significant outcomes were attributed to the 
more extensive personal contact with the nurse practitioner as well as risk-factor counselling 
in the intervention group compared to the control group. Overall, most studies demonstrated 
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no improvement in outcomes from nurse-led behavioural interventions (Schroeder et al. 
2005, Jiang et al. 2007, Guirado et al. 2011, Beune et al. 2014), whilst Nieuwkerk et al. 
(2012) study appeared to offer an opportunity to improve medication adherence. However, 
taking into consideration the baseline difference between groups, these study findings should 
be interpreted with caution. 
Discussion  
This review of interventions to enhance adherence to medications in cardiovascular care 
highlighted the varying effectiveness of approaches trialled, but also the varying methods of 
evaluation. The evidence of effectiveness presented for these interventions was inconsistent, 
due at least in part to the different cardiac disease populations and adherence measurement 
methods used in these studies. Results were not materially affected by age, sex or smoking 
(Wald et al. 2014) but the impact of socioeconomic status could not be determined; however, 
examination of the effect of these factors went beyond the review research question (Jiang et 
al. 2007).  
Motivational interviewing, either alone or combined with another adherence approach such as 
phone or text message education and reminders, appeared the most promising behavioural 
intervention for improving medication adherence, with potential for wide application across 
patients with different forms of cardiac disease. Interventions that utilised motivational 
interviewing (MINT) strategies were successful at maintaining medication adherence over 
time among hypertensive patients (Ogedegbe et al. 2008). The results support those of 
previous studies, demonstrating that MINT may be a useful approach for addressing 
medication adherence (DiIorio et al. 2008) because it enhance patient readiness to change, 
increase their confidence in their ability to overcome barriers, and increase self-motivation to 
achieve desired outcomes (Rollnick& Miller 1995). This approach entailed setting realistic 
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and specific goals for behaviour modification and prompted patients to follow their plan for 
behaviour change. This can be achieved when trained nurses integrate adherence behaviour 
into patients’ daily routines and reinforce the positive effect of MINT by follow-up using 
phone calls, text messaging, or mails as a mean of multifactorial intervention.   
Multifaceted interventions also demonstrated statistically significant improvement in 
medication adherence (Ho et al. 2014). Study findings were consistent with other successful 
multifaceted interventional studies, which have included medication review with a specific 
focus on regimen simplification (Bernsten et al. 2001), individualised patient education 
combined with medication reminders (Hawe& Higgins 1990), or a dose administration aid 
(Lee et al. 2006). These results also accorded with a study (Edworthy et al. 2007) that found 
significant improvement in adherence for both beta-blocking and lipid-lowering agents with 
counselling by nurses and pharmacists along with video, printed material, and phone follow-
up. Multifaceted interventions have broadly demonstrated promising results, but make it 
difficult to draw conclusions in favour of any particular combination of interventions or 
intensity because of the heterogeneity and complexity of interventions, compounded by 
multiple adherence measures (Topinková et al. 2012), and drug classes (van Eijken et al. 
2003). The cost of these interventions are also an important consideration for roll-out, this 
could not be determined as interventions were not described in sufficient detail. 
A common element of many medication adherence interventions was education. However, 
the methods of delivering education differed and outcomes were inconsistent. Effective 
nurse-based medication educational interventions included six monthly face to face education 
sessions (Hacihasanoğlu& Goözuöm 2011) about the important of regular medication taking, 
medication efficacy, possible side effects, and the importance of follow-up visits. Medication 
education was also successfully combined with automatic voice message reminders at one 
week and one month after hospital discharge for 12 months (Ho et al. 2014). By contrast, 
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written medication educational materials delivered by a nurse combined with three structured 
counselling sessions was not associated with significant improvement in medication 
adherence (Guirado et al. 2011, Beune et al. 2014).   
Comparisons across assessments of adherence was also difficult. The medication event 
monitoring system (MEMS), one of the most reliable objective assessment methods was 
expensive and not readily available for some dose forms (Remington et al. 2007, van den 
Boogaard et al. 2011). Subjective self-reporting measures are commonly used as they are 
relatively simple and less expensive; a number are well-validated and have been strongly 
correlated with objective measures of adherence in different populations (Nguyen et al. 
2014).  
For text and mail message interventions, studies showed similar improvements in medication 
adherence, at 16% (Wald et al. 2014) and 17% (Smith et al. 2008), respectively. These 
findings are consistent with recent RCTs reporting that bidirectional text messages resulted in 
statistically significant improvement in anti-retroviral treatment adherence among patients 
with Human Immunodeficiency Virus (Lester et al. 2010) and with hypertension (Márquez 
Contreras et al. 2005). Similarly, phone call interventions significantly improved adherence 
self-efficacy to antihypertensive medications at 10 months follow-up when combined with 
health promotion theory-based medication education and behavioural modification targeting 
patients’ life styles (Hacihasanoğlu& Goözuöm 2011). Cutrona et al. (2010)’s review 
concluded that phone calls both by trained lay people and by a nurse yielded significant 
improvements in cardiovascular adherence. Likewise, tailored telephone call nursing 
interventions reduced the time commitment, the cost for the care provider, provider costs, and 
improved medication adherence for patients with chronic diseases (Bosworth et al. 2009). 
However, a review by Mansoor et al. (2013) found that informational interventions had little 
or no impact on improving medication adherence. This could be due to how well health care 
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providers delivered the interventions, the patient groups, study design and differences in the 
relative contribution of each element to the intervention. For example, information supplied 
passively to the patient may not be adequate, and the additional element of requiring a 
response from the patient may be what was responsible for significant change. All in all, 
using technology in the form of phone message intervention provided by nurses appeared 
feasible, cost-effective and likely to be an effective tool to improve medication adherence in 
resource-limited settings.   
The results of nurse-led interventions were mixed although one study (Nieuwkerk et al. 2012) 
was successful in increasing adherence rates for lipid-lowering medications by enhancing 
patients’ knowledge through structured counselling sessions. A similar intervention was 
shown to be beneficial in patients with hypertension (Logan et al. 1983). Nurse-led 
interventions have also failed to show positive effects on medication adherence in other 
populations. For example Clarke et al. (2002) found no significant between-group differences 
in mean change scores of medicine taking after 12 months of a nurse-led diabetes 
management program. However, overall, the evidence is not adequate, with current studies 
limited by short follow-up, small sample size, and inconsistent adherence measures.  
To date, of nurse-delivered interventions to improve adherence to cardiovascular 
medications, multifaceted interventions appear to offer the best opportunities to optimise 
medication adherence, with component behavioural interventions in the form of motivational 
interviewing, educational content, text and/or phone messaging showing the greatest success. 
This review has some limitations. All papers reviewed were from English-language sources 
and published since 2004; study results may not represent less contemporary non English 
publications. The wide variety of medication adherence measurement methods utilised in 
these studies made it difficult to detect changes in adherence to medications, although, most 
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studies did use validated self-report questionnaires. Finally, the lack of concealment of 
randomisation allocation, blinding, self-reporting bias, and high rate of participant dropout in 
some studies could compromise the integrity of the study data. Hence, for each study, we 
examined potential biases that might explain differences among studies.  
Conclusion  
The prevalence of CVD is rising rapidly worldwide alongside emerging new and complex 
medication regimens which challenge both patients and healthcare providers (Hauptman 
2008). Of the interventions intended to improve adherence to cardiovascular medications 
tested by studies in this review, multi-component interventions, tailored to address the 
patients’ health behaviours, appeared to offer most promise. Combined interventions need to 
be detailed and employ multiple approaches such as motivational interviewing and education 
that target the desired behaviour change, and reinforcement of these behaviours such as with 
phone or text message strategies. However, whilst this review provides pointers for promising 
intervention approaches available to nurses, further studies are required to develop and test 
ways to accommodate these promising interventions within daily practice. It is imperative 
that interventions chosen are theory-based, and evaluated in robust trials to demonstrate 
effects on clinical outcomes, feasibility in usual practice settings, and sustainability. There is 
clearly a future role for technology in automating management of, for example, text and mail 
messaging. Healthcare providers in primary and secondary health settings should maximise 
the health benefits offered by medications by adopting those strategies shown to be effective 
at enhancing patients’ adherence to their medications. Researchers should clearly justify and 
specify methodologies to generate a cumulative body of knowledge that can be used to 
inform clinical practice. Further investigation of factors affecting long-term medication 
adherence is warranted to enable better targeting of interventions. 
20 
 
In summary, this review flags the enormous potential for future research and nursing practice 
development to significantly contribute to the care and outcomes of cardiac patients through 
optimising the benefits offered by medication schedules. Review findings indicate promising 
outcomes, but also highlight the current paucity of high quality research and knowledge 
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